Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Brief Potent Glutamatergic Modulation on Disordered Alcohol Use

NCT02539511 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT02539511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02539511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Brief Potent Glutamatergic Modulation on Disordered Alcohol Use
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2015
Completion date
December 31, 2017
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence